Q58-19855-43410
4 vaccinations
1 coded response
29 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 906 / CA
- Registered
- 2021-01-09
- Relationship
- Self
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Registered dependents
3HT-29283-72958
Child or adolescent in my care · Female · 2022-07-06
7U3-29567-54987
Child or adolescent in my care · Female · 2022-10-13
Timeline
-
2020-12-17
Dose 1 — Pfizer-BioNTech
-
2021-01-07
Dose 2 — Pfizer-BioNTech
-
2021-01-09
Registered in v-safe
-
2021-01-09
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Swelling · Fever · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-01-09
Report sent to call center — days 1–6 daily, dose 2Be unable to work · Be unable to do your normal daily activities1 call case(s)
- 2021-01-10
- 2021-01-11
- 2021-01-12
- 2021-01-13
- 2021-01-14
- 2021-01-21
- 2021-01-28
- 2021-02-06
- 2021-02-13
- 2021-02-18
- 2021-04-10
- 2021-07-08
-
2021-10-14
Dose 3 — Pfizer-BioNTech
-
2021-10-15
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Chills, Headache, Muscle or body achesAdult check-in
- 2021-10-16
- 2021-10-17
- 2021-10-18
- 2021-10-19
- 2021-10-20
- 2021-10-21
- 2021-10-28
- 2021-11-04
- 2021-11-11
- 2021-11-18
- 2021-11-25
- 2022-01-13
-
2022-04-14
Survey response — 6 months, dose 3MedDRA: Cough, Pyrexia, Rhinorrhoea — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Fever, cough, runny noseMedDRA releases: 2024-11 · check-in free text available
-
2022-10-12
Dose 4 — Moderna
- 2022-10-14
- 2023-01-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-17 | Pfizer-BioNTech | |
| 2 | 2021-01-07 | Pfizer-BioNTech | |
| 3 | 2021-10-14 | Pfizer-BioNTech | No |
| 4 | 2022-10-12 | Moderna | No |
Call center
1 call center case
1 priority 2/3 (triaged and no follow up)
Free text
Release 11 — 6 months, dose 3
Symptoms: Fever, cough, runny nose
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release